Publications by authors named "Scott Shuldiner"

Claim this Profile
U
Utility Assessment of Follow-up Evaluation for Commotio Retinae.
Henry W Zhou, Sandra Hoyek, Shravan V Savant, Scott R Shuldiner, Grayson W Armstrong

J Vitreoretin Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Time Adverse Events in Pediatric Fluorescein Angiography: IV versus Oral.
Osama Sorour, Naira Ikram, Scott Shuldiner, Samet Gulkas, Francisco Altamirano

Ophthalmol Retina· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular Blast Injuries in Military and Civilian Mass-casualty Settings.
Scott R Shuldiner, Daniel Hu, Yoshihiro Yonekawa, Dean Eliott, Thomas Dohlman

Int Ophthalmol Clin· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocardial extracellular volume fraction is positively associated with activated monocyte subsets among cART-treated persons living with HIV in South Africa.
Tess E Peterson, Muki Shey, Nomawethu Masina, Lye-Yeng Wong, Scott R Shuldiner

Int J Cardiol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting eyes at risk for rapid glaucoma progression based on an initial visual field test using machine learning.
Scott R Shuldiner, Michael V Boland, Pradeep Y Ramulu, C Gustavo De Moraes, Tobias Elze

PLoS One· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocardial Fibrosis Among Antiretroviral Therapy-Treated Persons With Human Immunodeficiency Virus in South Africa.
Scott R Shuldiner, Lye-Yeng Wong, Tess E Peterson, Julian Wolfson, S Jermy

Open Forum Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PharmGKB summary: isoniazid pathway, pharmacokinetics.
Daniel J Klein, Sotiria Boukouvala, Ellen M McDonagh, Scott R Shuldiner, Nicola Laurieri

Pharmacogenet Genomics· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of function mutation in glutamic pyruvate transaminase 2 (GPT2) causes developmental encephalopathy.
Katrina Celis, Scott Shuldiner, Eden V Haverfield, Joshua Cappell, Rongze Yang

J Inherit Metab Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PharmGKB summary: peginterferon-α pathway.
Scott R Shuldiner, Li Gong, Andrew J Muir, Russ B Altman, Teri E Klein

Pharmacogenet Genomics· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential phosphorylation of a regulatory subunit of protein kinase CK2 by target of rapamycin complex 1 signaling and the Cdc-like kinase Kns1.
Manuel E Sanchez-Casalongue, Jaehoon Lee, Aviva Diamond, Scott Shuldiner, Robyn D Moir

J Biol Chem· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study identifies genetic variants in GOT1 determining serum aspartate aminotransferase levels.
Haiqing Shen, Coleen Damcott, Scott R Shuldiner, Sumbul Chai, Rongze Yang

J Hum Genet· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis